1. Home
  2. SPRC vs PRFX Comparison

SPRC vs PRFX Comparison

Compare SPRC & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRC
  • PRFX
  • Stock Information
  • Founded
  • SPRC 2004
  • PRFX 2007
  • Country
  • SPRC Israel
  • PRFX Israel
  • Employees
  • SPRC N/A
  • PRFX N/A
  • Industry
  • SPRC Biotechnology: Pharmaceutical Preparations
  • PRFX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPRC Health Care
  • PRFX Health Care
  • Exchange
  • SPRC Nasdaq
  • PRFX Nasdaq
  • Market Cap
  • SPRC 3.5M
  • PRFX 3.8M
  • IPO Year
  • SPRC N/A
  • PRFX 2020
  • Fundamental
  • Price
  • SPRC $0.27
  • PRFX $2.24
  • Analyst Decision
  • SPRC
  • PRFX Hold
  • Analyst Count
  • SPRC 0
  • PRFX 1
  • Target Price
  • SPRC N/A
  • PRFX N/A
  • AVG Volume (30 Days)
  • SPRC 180.7K
  • PRFX 3.8M
  • Earning Date
  • SPRC 02-15-2025
  • PRFX 05-14-2025
  • Dividend Yield
  • SPRC N/A
  • PRFX N/A
  • EPS Growth
  • SPRC N/A
  • PRFX N/A
  • EPS
  • SPRC N/A
  • PRFX N/A
  • Revenue
  • SPRC $1,306,000.00
  • PRFX N/A
  • Revenue This Year
  • SPRC N/A
  • PRFX N/A
  • Revenue Next Year
  • SPRC N/A
  • PRFX N/A
  • P/E Ratio
  • SPRC N/A
  • PRFX N/A
  • Revenue Growth
  • SPRC N/A
  • PRFX N/A
  • 52 Week Low
  • SPRC $0.20
  • PRFX $0.43
  • 52 Week High
  • SPRC $1.79
  • PRFX $16.63
  • Technical
  • Relative Strength Index (RSI)
  • SPRC 40.64
  • PRFX 47.70
  • Support Level
  • SPRC $0.25
  • PRFX $2.20
  • Resistance Level
  • SPRC $0.33
  • PRFX $2.37
  • Average True Range (ATR)
  • SPRC 0.02
  • PRFX 0.26
  • MACD
  • SPRC 0.00
  • PRFX 0.06
  • Stochastic Oscillator
  • SPRC 26.28
  • PRFX 30.94

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

About PRFX PainReform Ltd.

PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.

Share on Social Networks: